Back to homepage

Tag "Biocon Biologics"

Biocon Biologics offers 15% stake to SII subsidiary for 100 mn vax doses

Biocon Biologics offers 15% stake to SII subsidiary for 100 mn vax doses

🕔10:30, 17.Sep 2021

Bengaluru, Sep 17 (IANS) Biocon Biologics, a subsidiary of Biocon, on Thursday offered approximately 15 per cent stake to Serum Institute Life Sciences (SILS) for 100 million doses of vaccines in a strategic alliance. SILS is a subsidiary of Pune-based Serum

Read Full Article